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 Abstract - Calcium (Ca
2+
) is a universal second 
messenger that regulates a number of diverse cellular 
processes including cell proliferation, development, 
motility, secretion, learning and memory
1, 2
. A variety of 
stimuli, such as hormones, growth factors, cytokines, and 
neurotransmitters induce changes in the intracellular 
levels of Ca
2+
. The most ubiquitous and abundant protein 
that serves as a receptor to sense changes in Ca
2+
 
concentrations is Calmodulin (CaM), thus mediating  the 
role as second messenger of this ion. The Ca
2+
/CaM 
complex initiates a plethora of signaling cascades that 
culminate in alteration of cell functions. Among the many 
Ca
2+
/CaM binding proteins, the multifunctional protein 









I.  INTRODUCTION 
 
 The general structure of CaMKs includes an N-
terminal kinase domain, an autoregulatory domain, an 
overlapping CaM-binding domain and, in phosphorylase 
kinase and CaMKII, a C-terminal association domain that 
is  essential for multimerization and targeting.  
The best characterized CaM Kinase is CaMKII
3
.CaMKII 
is a multimeric enzyme composed of 12 subunits and it is 
encoded by 4 separate genes () with at least 24 
peptides generated by alternate splicing
4, 5
and at least one 
isoform expressed in every cell type
6
. CaMKII has a 
distinct mechanism of regulation that differs from the 
others CaM kinases. One catalytic subunit phosphorylates 
the autoinhibitory domain of the adjacent subunit on T286 
(in the  isoform). This event requires that both the 











Autophosphorylation of T286 increases affinity for CaM 
by decreasing the rate of CaM dissociation. CaM is 
trapped by autophosphorylation, so that even when Ca
2+
 
levels are reduced, the kinase is fully active until CaM 
dissociates (several hundreds of seconds
13
). This could 
serve as a mechanism to increase the sensitivity of 
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CaMKIV is a serine/threonine protein kinase that has 
been localized also in the nucleus
14
. Its expression is 
tissue-specific, with expression restricted primarily to 
distinct regions of the brain, T-lymphocytes, and 
postmeiotic germ cells,
15, 16
 although it has been found in 
other cell types 
17
, being especially enriched in cerebellar 
granule cells. CaMKIV (one gene, two splice variants)
18
 – 
is a monomeric enzyme, and apart from activation by 
Ca
2+
/CaM, shows very different modes of regulation by 
phosphorylation compared to CaMKII. CaMKIV has an 
“activation loop” phosphorylation site that is absent in 
CaMKII. Binding of Ca2+/CaM to CaMKIV exposes this 
activation loop site to allow phosphorylation by the 





. Phosphorylation of the activation loop in 
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II.  CaMK-MEDIATED ACTIVATION OF 
TRANSCRIPTION. 
 
 CaMKII and CREB 
 
 As CaM kinases II and IV have quite similar substrate 
specificity determinants, it is not completely surprising 
that they sometimes phosphorylate the same proteins. One 
such in vitro substrate for these kinases is the cAMP-
response element binding protein, CREB. CaMKII can  
phosphorylate CREB at Ser133 residue  leading to the 
speculation that CaMKII mediates the Ca
2+
 requirement 
for expression of the immediate early genes
5
. However, 
while the truncated form of CaMKII can stimulate CREB-
mediated transcription in some cells, it is inhibitory in 
others. Sun et al. 
20
discovered that in addition to Ser-133, 
CaMKII also phosphorylated a second residue on CREB, 
Ser-142. Indeed, phosphorylation of Ser-142 was not only 
inhibitory, but this modification was also dominant and 
could reverse the activation of CREB resulting from its 
phosphorylation on Ser-133 by PKA. This 
phosphorylation seems to be destabilizing for the 
association between CREB and CBP
21
. Interestingly, the 
nature of the effect of CaMKII on transcription is both 
cell and promoter dependent. 
 
CaMKIV AND CREB 
 
CaMKIV shows very strong nuclear localization
22, 23
, 
and many studies support the idea that it is responsible for 
Ca
2+
-dependent stimulation of transcription through 
phosphorylation of CREB and serum response factor 
(SRF)
5, 22, 24
. Activation by CaMKIV occurs via direct 
phosphorylation of the activating serines of these 
transcription factors, Ser133 (CREB), Ser63 (ATF-1), and 
Ser103(SRF), respectively
25
. CaMKIV phosphorylates 
CREB Ser133, the same site that is phosphorylated by 
PKA. Transfected CaMKIV alone is a relatively poor 
stimulator of transcriptional activation by CREB: indeed, 
cotransfection of CaMKK with CaMKIV gives a 14-fold 
enhancement of transcription
26
. Studies in cultured 
hippocampal neurons indicate that CaMKIV regulates 
CREB-dependent gene transcription in response to 
electrical stimulation or KCl depolarization
27
. This role of 
CaMKIV in CREB-mediated transcription has been 
confirmed in transgenic mice that express an inactive 
form of CaMKIV only in T cells in the thymus
27
. 
Overexpression of inactive CaMKIV would be expected 
to function in a dominant negative manner. These thymic 
T cells have a reduced ability, upon stimulation, to 
phosphorylate CREB, induce transcription of FosB and 
produce interleukin 2 (IL-2)
28
. There is also good 
evidence for involvement of CaMKIV in transcriptional 
regulation of the BDNF gene through phosphorylation of 
a CREB family member
29
. 
These observations provide a mechanism that would 
permit the Ca
2+
 signaling pathway to be either 
antagonistic or additive with the cAMP pathway for 
activation of CREB, depending on the relative activity of 
specific CaM kinases. 
 
 





 observed that CaMKII promotes SGN 
survival, at least in part, by functionally inactivating Bad. 
The ability of Bad to move from the cytoplasm to the 
mitochondria, where it can carry out its pro-apoptotic 
function, is regulated by phosphorylation 
31, 32
. Thus, Bad 
plays a central role in the regulation of apoptosis. CaMKII 
also regulates apoptosis by inactivating Bad. One 
phosphorylation site on Bad, Ser170
33
, is a potential 
CaMKII target, raising the possibility that CaMKII 
phosphorylates Bad directly. However, co-expression of 
Bad and truncated form of CaMKII(1-290) in PC12 cells 
results in Bad hyper-phosphorylation, including 
phosphorylation of Ser112. This implies an indirect 
pathway for Bad phosphorylation by CaMKII. The 
mechanism by which CaMKII inactivates Bad involves 
multiple signaling pathways, and  differs among cell 
types. CaMKII also suppresses nuclear translocation of 
histone deacetylase, thereby promoting neuronal 
survival
34
.  Indeed, CaMKII has been shown to activate 
the pro-survival transcriptional regulator NF-κB in T 
lymphocytes and in neurons
35
. Because dominant-
negative CREB constructs do not reduce the pro-survival 
effect of CaMKII, it is unlikely that CREB is the nuclear 
target of CaMKII. The depolarization also promotes 
survival by recruiting a nuclear pathway involving 
CaMKIV and CREB
30
. This is supported by the 
observations that dominant-inhibitory CaMKIV and 
dominant-inhibitory CREB both reduce the ability of 
depolarization to promote survival and dominant-
inhibitory CREB blocks the ability of CaMKIV to 
promote survival. They also used a constitutively-active 
CREB mutant, CREBDIEDML, and found that it failed to 
support SGN survival. Probably the level of 
transcriptional activation given by CREBDIEDML is 
insufficient to promote survival. Alternatively, 
recruitment of CBP by CREB is necessary but is not 
sufficient for promotion of survival via CREB-dependent 
gene expression.  
 
 
IV. CaMKs MEDIATED REGULATION OF 
PROLIFERATION 
 
Cell proliferation is regulated by converging signals on 
the cell cycle machinery that determine whether the cell 
stays in the G1 phase or proceeds to S phase. The 
progression through G1 into the DNA synthesizing S 
phase is driven by cyclin-dependent kinase (CDK)4 and 
CDK6, that interact with the cyclin D family of proteins, 
and CDK2, that interacts with cyclins A/E  
36
. The 
Ras/Raf/Mek/Erk cascade plays a pivotal role in the 
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control of this process: indeed, sustained Erk activation is 
required to pass the G1 restriction point and regulate 
cyclin D1 expression during mid-G1 phase 
37, 38
. CaMKII 
plays a pivotal role in the modulation of Erk activation in 
a number of cell models. A crosstalk between CaMKII 
and Erk pathway was first demonstrated in response to 
cell adhesion to the extracellular matrix in thyroid cells. 
CaMKII participates to Raf1 activation and controls Erk 
phosphorylation following integrin stimulation by 
fibronectin 
39, 40
. Indeed, the link between Ca
2+
 signaling 
and the ERK pathway has been documented 
38, 41
: ERK is 
activated by a CaMKII and Raf-dependent mechanism 
42
, 
and CaMKII facilitates adhesion-dependent activation of 
ERK in VSMCs 
41, 43
. CaM antagonist or  CaMKII 
inhibitors attenuate ERK activation in response to several 
stimuli 
44
, and coexpression of CaMKII or a CaMKII 
inactive mutant in CHO cells down-regulates Ca
2+
-
induced ERK activation 
15, 45
. These data suggest that 
CaMKII and ERK are essential mediators of cell 
proliferation 
46, 47
. The role of CaMKII in cell 
proliferation is not a restricted mechanism, but it is a 
general phenomenon that may be relevant for the 









The multifunctional CaMKs family proteins are involved 
in the control of differentiation and survival of neurons 
and hematopoietic stem cells 
48
. In the cerebellum, 
granule and Purkinje cells (PCs) develop synergistically, 
and alterations in the developmental program of either 
cell type affects the other  
45
. Many studies showed that 
the absence of CaMKIV results in abnormal PCs, 
characterized by a decreased number of mature cells 
together with stunted arborization and altered parallel 
fiber synaptic currents of the remaining cells 
21, 49
. 
Kobubo et al hypothesized that these adult defects may 
arise from developmental issues involving CGCs in 
addition to PCs. These cells only express CaMKIV during 
a briefperiod between late embryogenesis and early 
postnatal development, whereas CGCs express both 
CaMKIV and its upstream activator CaMKK2 from early 
postnatal development through adulthood 
50
 .CaMKIV 
exert prosurvival functions. Inneurons, BDNF signaling 
through TrKB inhibits apoptosis through the MAP and PI-
3 kinase/AKT pathways 
15
.CaMKIV has a prosurvival 
role in multiple cell types including hematopoietic stem 
cells(HSCs) 
51




The hematopoietic stem cell (HSC) gives rise to all 
mature, terminally differentiated cells of the blood. 
CaMKIV is involved in early hematopoietic development, 







cells (KLScells), a cell 
population that includes long-term and short term 
hematopoietic stem cells as well as other multipotent 
progenitor cells 
53
. Camk4 gene is expressed in KLS cells, 
and CaMKIV is required for KLS cells to repopulate the 
bone marrow in transplantation assays. Camk4
-/-
KLS cells 
display enhanced proliferation as well as increased 
apoptosis, in vivo and in vitro, compared with wild type 
(WT) cells and have decreased levels of phospho-CREB 
(pCREB), CBP, Bcl-2 mRNA and Bcl-2 protein. Re-
expression of CaMKIV in Camk4
-/-
KLS cells restores 
Bcl-2 and CBP levels and rescues the proliferation 
defects. 
Many critical biological functions involve Ca
2+
 signaling 
in DC. For example, apoptotic body engulfment and 
processing are accompanied by a rise in intracellular 
Ca
2+





chemotactic molecules produce Ca
2+
 increases in DC, 
55
 
suggesting the involvement of a Ca
2+
-dependent pathway 
in the regulation of DC migration. The role of a Ca
2+
-
dependent pathway in the mechanism regulating DC 
maturation is suggested by the opposite effects induced by 
Ca
2+
 ionophores or chelation of extracellular Ca
2+
 on this 
process
56
. The pharmacologic inhibition of CaMKs as 
well as ectopic expression of kinase-inactive CaMKIV 
decrease the viability of monocyte-derived DCs exposed 
to bacterial LPS. Although isolated Camk4
−/−
 DCs are 
able to acquire the phenotype typical of mature cells and 
release normal amounts of cytokines in response to LPS, 
they fail to accumulate pCREB, Bcl-2, and Bcl-xL and 





CaMKII has been implicated in several key aspects of 
acute cellular Ca
2+
 regulation related to cardiac excitation-
contraction (E-C) coupling. CaMKII phosphorylates 
sarcoplasmic reticulum
57
 proteins, including the 
ryanodine receptors (RyR2) and phospholamban (PLB)
57
 . 
Contractile dysfunction develops with hypertrophy, 






expression and activity are altered in the myocardium of 





, and in cardiac tissue from patients with 
dilated cardiomyopathy 
61
.Several transgenic mouse 
models have confirmed a role for CaMK in the 
development of cardiac hypertrophy. Hypertrophy 
develops in transgenic mice that overexpress CaMKIV  
62
, 
but this isoform is not detectable in the heart and 
CaMKIV knockout mice still develop hypertrophy 
following transverse aortic constriction (TAC) 
63
. CaMKII 







 and a-skeletal 
actin
61
. The nuclear localization signal of CaMKIIB was 
shown to be required for this hypertrophic response, as 
transfection of CaMKIIC did not result in enhanced 
ANF expression
67, 68
. MEF2 has been suggested to act as a 
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common endpoint for hypertrophic signaling pathways in 
the myocardium,
66
 and studies using CaMKIV transgenic 
mice crossed with MEF2 indicator mice suggest that 
MEF2 is a downstream target for CaMKIV 
69
. Recent 
studies have demonstrated that MEF2 can interact with 
class II histone deacetylases (HDACs), a family of 
transcriptional repressors, as well as with other repressors 
that limit MEF2-dependent gene expression. Notably, 
constitutively activated CaMKIV have been shown to 
activate MEF2 by phosphorylating and dissociating 




VI. CaMKs AND INFLAMMATION 
 
Sepsis is a special type of host inflammatory response to 
bacterial infection that originates from massive and 
widespread release of pro-inflammatory mediators. 
Bacterial endotoxins, such as LPS, are the major 
offending factors in sepsis that activate TLR-mediated 
signaling to generate inflammatory response that is 
amplified in a self-sustaining manner. There are meny 
evidences of a  correlation between multifunctional CaM 
kinases and TLR-4 signaling. CaMKII directly 
phosphorylates components of TLR signaling, and 
promotes cytokine production in macrophages
71
. 
Complement activation is also a recognized factor in the 
pathogenesis of sepsis. Inhibition of the complement 
cascade decreases inflammation and improves mortality 
in animal models
51
. Differentiation and survival of 
antigen presenting dendritic cells (DC) uponTLR-4 
activation requires CaMKIV
72
. DC from 
CaMKIV−/−mice failed to survive upon LPS-mediated 
TLR-4 induction. However, ectopic expression of 
CaMKIV was able to rescue this defect. In another study, 
the selective inhibition of CaMKII interfered with 
terminal differentiation of monocyte-derived DCs by 
preventing up-regulation of co-stimulatory and MHC II 
molecules as well as secretion of cytokines induced by 
TLR-4 agonists
73
. Thus, CaM kinases seem to play a 
general role in inflammatory processes 
 
VII. CONCLUSIONS 
CaMKs define a family of ser-thr kinases that direct a 
wide range of cellular processes and cell fate decisions. 
Since their discovery, much of the focus has been on their 
regulation of memory and learning. In recent years, 
studies on CaMKII and CaMKIV signaling in a number of 
cell models have established the importance of the Ca
2+-
CaM-CaMKK-CaMKs pathways in effecting 
proliferation, survival, differentiation and associated 
molecular events. Intriguing new findings also indicate 
that, although the two kinases might share some 
substrates, there is specificity in the pathways they 
contribute, thus reflecting both shared and unique 
properties. The emergence of ERK as a critical CaMKII 
regulatory target for cell proliferation has united 
membrane proximal regulatory events orchestrated by the 




 is ubiquitously present in the cells, hence its 
compartimentalization and the regulation of its 
downstream kinases need to be finely tuned, in order to 
efficiently regulate biological functions. The involvement 
of CaMKII and CaMKIV in pathways that regulate 
functions as different as proliferation, survival and 
differentiation imply numerous cross-talks and their 
harmonization. Both kinases require Ca
2+
 increases to be 
activated, although other events are required to support 
their differential activation. Subcellular 
compartimentalization provides another tool to 
distinctively activate CaMKII and CaMKIV depending 
upon the cell’s needs. It is possible, though, to 
hypothesize a further mechanism of counter-regulation 
between the two kinases: insights into the regulation and 
impact of a crosstalk between CaMKII and CaMKIV 
signaling might bring in new highlights for biological 
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